失衡的炎症细胞因子反应与脓毒症死亡率无关:一项前瞻性队列研究
这项前瞻性观察性队列研究在荷兰两家三级混合ICU连续纳入2011至2013年严重脓毒症或脓毒性休克患者708例,重复测量血浆白介素-6和白介素-10浓度。分析显示白介素-6和白介素-10各自独立与死亡率相关,但以白介素-6与白介素-10交互项建模的炎症平衡与ICU入科时、第4天及ICU出科时的死亡率均无显著关联。第4天的炎症失衡与ICU获得性感染的发生相关(亚分布风险比0.87,95%CI 0.77-0.98)。作者结论认为炎症介质平衡似乎不影响脓毒症患者的早期、中期或晚期死亡。
要点
- 708例严重脓毒症或脓毒性休克患者中,86例(12%)在4天内死亡,140例(20%)在第4至28天死亡,另有155例(22%)在1年内死亡。
- 白介素-6和白介素-10水平均独立与死亡率相关,但两者交互项(炎症平衡)与死亡率无关:入科时相对风险0.99(95%CI 0.95-1.04),第4天1.02(95%CI 0.98-1.06),ICU出科时1.12(95%CI 0.98-1.29)。
- 第4天炎症失衡与ICU获得性感染发生相关(亚分布风险比0.87,95%CI 0.77-0.98)。
- 作者结论认为,炎症介质平衡似乎不影响脓毒症患者入住ICU后的早期、中期或晚期死亡。
适用人群与场景
- 2011至2013年在荷兰两家三级混合ICU连续纳入的严重脓毒症或脓毒性休克患者。
研究设计与关键结果
- 研究类型为前瞻性观察性队列,纳入708例严重脓毒症或脓毒性休克患者,来自荷兰两家三级混合ICU。
- 主要终点为炎症平衡(白介素-6与白介素-10交互项)与死亡率的关联:入科时相对风险0.99(95%CI 0.95-1.04),第4天相对风险1.02(95%CI 0.98-1.06),ICU出科时相对风险1.12(95%CI 0.98-1.29)。
- 白介素-6和白介素-10水平均独立与死亡率相关。
- 次要终点:第4天炎症失衡与ICU获得性感染发生相关(亚分布风险比0.87,95%CI 0.77-0.98)。
- 死亡分布:86例(12%)在4天内死亡,140例(20%)在第4至28天死亡,另有155例(22%)在1年内死亡。
证据类型、等级与局限
- 证据类型:前瞻性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,白介素-6和白介素-10的平衡似乎不影响脓毒症患者入住ICU后的早期、中期或晚期死亡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The prevailing theory of host response during sepsis states that an excessive production of pro-inflammatory mediators causes early deaths, whereas a predominantly anti-inflammatory response may lead to immunosuppression, secondary infection, and late deaths. We assessed inflammatory (im)balance by measuring pro-inflammatory interleukin-6 and anti-inflammatory interleukin-10 during three distinct time periods after sepsis, and assessed its association with mortality.
DESIGN: Prospective observational cohort.
SETTING: Two tertiary mixed ICUs in The Netherlands.
PATIENTS: Consecutive patients presenting with severe sepsis or septic shock from 2011 to 2013.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We repeatedly measured plasma interleukin-6 and interleukin-10 concentrations using cytometric bead array. Poisson regression was used to analyze the relation between inflammatory markers measured on 1) ICU admission and day 4 mortality, 2) day 4 and day 28 mortality, and 3) ICU discharge and 1-year mortality. Secondary outcome was development of ICU-acquired infections. Among 708 patients, 86 (12%) died within 4 days, 140 (20%) died between days 4 and 28, and an additional 155 (22%) died before 1 year. Interleukin-6 and interleukin-10 levels were both independently associated with mortality, but the balance of this response as modelled by an interleukin-6 and interleukin-10 interaction term was not (relative risk, 0.99; 95% CI, 0.95-1.04 on admission; relative risk, 1.02; 95% CI, 0.98-1.06 on day 4; and relative risk, 1.12; 95% CI, 0.98-1.29 at ICU discharge). However, inflammatory imbalance on day 4 was associated with development of ICU-acquired infections (subdistribution hazard ratio, 0.87; 95% CI, 0.77-0.98).
CONCLUSIONS: Although both interleukin-6 and interleukin-10 productions are associated with death, the balance of these inflammatory mediators does not seem to impact either early, intermediate, or late mortality in patients presenting to the ICU with sepsis.
参考来源
- Frencken JF, van Vught LA, Peelen LM, et al. An Unbalanced Inflammatory Cytokine Response Is Not Associated With Mortality Following Sepsis: A Prospective Cohort Study. Crit Care Med. 2017. PMID: 28257334. doi:10.1097/CCM.0000000000002292
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。